# US 2008/0188528 A1 · Modulators of C3a receptor and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188528 A1
- Document ID: US20080188528A1
- Status: Published application
- Kind: A1
- Application number: 12/004,956
- Filed: 2007-12-21
- Published: 2008-08-07
- Earliest claimed: 2006-12-22
- Inventors: Ronald J. Biediger; Huong M. Bui; Jie Chen; Kevin M. Henry; Thomas Thrash
- Web page: https://patentgrep.com/patent/US20080188528A1

## CPC

- C07D 213/82: in position 3
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 13/12: of the kidneys
- A61P 15/08: for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A61P 17/00: Drugs for dermatological disorders
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 19/10: for osteoporosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/04: Antibacterial agents
- C07D 213/81: Amides; Imides
- C07D 279/14: condensed with carbocyclic rings or ring systems
- C07D 279/22: with carbon atoms directly attached to the ring nitrogen atom
- C07D 307/68: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D 333/70: attached in position 2
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 409/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided are compounds that are modulators of C3a receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, the compounds are pyridones. In certain embodiments, provided are methods for treatment or amelioration of diseases associated with modulation of C3a receptor activity.

## Claims

### Claim 1

A compound of Formula I:
or pharmaceutically acceptable derivatives thereof,
wherein A1 is arylene, heteroarylene or heterocyclylene;
R1 is aryl, aralkyl, alkylaryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heteroarylalkyl;
R2 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl;
R5 is OR or NR5aR5b;
R5a and R5b are selected as follows:
i) R5a and R5b are each independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl; or
ii) R5a and R5b together with the nitrogen atom on which they are substituted form a 3-7 membered heterocyclic or heteroaryl ring;
A4 is alkylene, alkenylene, alkynylene, alk(en)(yn)ylene, cycloalkylene, arylene, aralkylene, alkylarylene, heteroarylene or heterocyclylene;
R3 and R4 are selected as follow:
i) R3 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl; and R4 is R3, —C(═R6)NR7R8, —C(═NR)R, —C(O)R9, —S(O)R9, —S(O)2NHR9a —C(O)NHR9a or CH2)xOH;
ii) R3 and R4 together form ═CRNR5aR5b; or
iii) R3 is absent, hydrogen or lower alkyl and R4 forms a 5-7 membered heteroaromatic or heterocyclic ring with along with A4 and the nitrogen atom on which it is substituted;
each R is independently hydrogen, hydroxy, alkoxy, alkyl, alkenyl, alkynyl, aryl, alkylaryl, heteroaryl, heterocyclyl, cycloalkyl or aralkyl;
R6 is NR6x or O;
R6x is hydrogen, hydroxy, alkyl, alkenyl, alkynyl, aryl, alkoxy, C(O)R9 or S(O)nR9;
R7 and R8 are selected as follows:
i) R7 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl; and R8 is selected from R7, nitro, C(O)R9 and S(O)nR9; or
ii) R7 and R8 together with the nitrogen atom on which they are substituted form a 3-7 membered heterocyclic or heteroaryl ring;
R9 is hydrogen, hydroxy, alkyl, haloalkyl, alkenyl, alkynyl, aryl, alkylaryl, heterocyclyl, cycloalkyl, aralkyl, alkoxy, alkenyloxy, alkynyloxy, aryloxy, alkylaryloxy, heterocyclyloxy, cycloalkyloxy or aralkoxy;
R9a is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl;
r1 is 0-3; r2 is 0-3; n is 0-2 and x is 1-6,
where R, R1—R9, A1, R5a, R5b, R6x and R9a are optionally substituted with 1, 2, 3 or 4 substituents, each independently selected from Q1, where Q1 is halo, pseudohalo, hydroxy, oxo, thioxo, nitrile, nitro, formyl, mercapto, hydroxycarbonyl, hydroxycarbonylalkyl, alkyl, haloalkyl, polyhaloalkyl, aminoalkyl, diaminoalkyl, alkenyl containing 1 to 2 double bonds, alkynyl containing 1 to 2 triple bonds, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, aryl, heteroaryl, aralkyl, aralkenyl, aralkynyl, heteroarylalkyl, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl, triarylsilyl, alkylidene, arylalkylidene, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, alkoxycarbonylalkyl, aryloxycarbonyl, aryloxycarbonylalkyl, aralkoxycarbonyl, aralkoxycarbonylalkyl, arylcarbonylalkyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, arylaminocarbonyl, diarylaminocarbonyl, arylalkylaminocarbonyl, alkoxy, aryloxy, heteroaryloxy, heteroaralkoxy, heterocyclyloxy, cycloalkoxy, perfluoroalkoxy, alkenyloxy, alkynyloxy, aralkoxy, alkylcarbonyloxy, arylcarbonyloxy, aralkylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, aralkoxycarbonyloxy, aminocarbonyloxy, alkylaminocarbonyloxy, dialkylaminocarbonyloxy, alkylarylaminocarbonyloxy, diarylaminocarbonyloxy, guanidino, isothioureido, ureido, N-alkylureido, N-arylureido, N′-alkylureido, N′,N′-dialkylureido, N′-alkyl-N′-arylureido, N′,N′-diarylureido, N′-arylureido, N,N′-dialkylureido, N-alkyl-N′-arylureido, N-aryl-N′-alkylureido, N,N′-diarylureido, N,N′,N′-trialkylureido, N,N′-dialkyl-N′-arylureido, N-alkyl-N′,N′-diarylureido, N-aryl-N′,N′-dialkylureido, N,N′-diaryl-N′-alkylureido, N,N′,N′-triarylureido, amidino, alkylamidino, arylamidino, aminothiocarbonyl, alkylaminothiocarbonyl, arylaminothiocarbonyl, amino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, arylaminoalkyl, diarylaminoalkyl, alkylarylaminoalkyl, alkylamino, dialkylamino, haloalkylamino, arylamino, diarylamino, alkylarylamino, alkylcarbonylamino, alkoxycarbonylamino, aralkoxycarbonylamino, arylcarbonylamino, arylcarbonylaminoalkyl, aryloxycarbonylaminoalkyl, aryloxyarylcarbonylamino, aryloxycarbonylamino, alkylsulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, heterocyclylsulfonylamino, heteroarylthio, azido, —N+R51R52R53, P(R50)2, P(O)(R50)2, OP(═O)(R50)2, —NR60C(═O)R63, dialkylphosphonyl, alkylarylphosphonyl, diarylphosphonyl, hydroxyphosphonyl, alkylthio, arylthio, perfluoroalkylthio, hydroxycarbonylalkylthio, thiocyano, isothiocyano, alkylsulfinyloxy, alkylsulfonyloxy, arylsulfinyloxy, arylsulfonyloxy, hydroxysulfonyloxy, alkoxysulfonyloxy, aminosulfonyloxy, alkylaminosulfonyloxy, dialkylaminosulfonyloxy, arylaminosulfonyloxy, diarylaminosulfonyloxy, alkylarylaminosulfonyloxy, alkylsulfinyl, alkylsulfonyl, arylsulfinyl, arylsulfonyl, hydroxysulfonyl, alkoxysulfonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, diarylaminosulfonyl or alkylarylaminosulfonyl; or two Q1 groups, which substitute atoms in a 1, 2 or 1,3 arrangement, together form alkylene, alkylenoxy (i.e., —O—(CH2)y—), alkylenthioxy (i.e., —S—(CH2)y—), alkylenedioxy (i.e., —O—(CH2)y—O—), thioalkylenoxy (i.e., —S—(CH2)y—O—) or alkylenedithioxy (i.e., —S—(CH2)y—S—) where y is 1 or 2; or two Q1, groups, which substitute the same atom, together form an alkylene; and
each Q1 is independently unsubstituted or substituted with one, two or three substituents, each independently selected from Q2;
each Q2 is independently halo, pseudohalo, hydroxy, oxo, thioxo, nitrile, nitro, formyl, mercapto, hydroxycarbonyl, hydroxycarbonylalkyl, alkyl, haloalkyl, polyhaloalkyl, aminoalkyl, diaminoalkyl, alkenyl containing 1 to 2 double bonds, alkynyl containing 1 to 2 triple bonds, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, aryl, heteroaryl, aralkyl, aralkenyl, aralkynyl, heteroarylalkyl, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl, triarylsilyl, alkylidene, arylalkylidene, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, alkoxycarbonylalkyl, aryloxycarbonyl, aryloxycarbonylalkyl, aralkoxycarbonyl, aralkoxycarbonylalkyl, arylcarbonylalkyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, arylaminocarbonyl, diarylaminocarbonyl, arylalkylaminocarbonyl, alkoxy, aryloxy, heteroaryloxy, heteroaralkoxy, heterocyclyloxy, cycloalkoxy, perfluoroalkoxy, alkenyloxy, alkynyloxy, aralkoxy, alkylcarbonyloxy, arylcarbonyloxy, aralkylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, aralkoxycarbonyloxy, aminocarbonyloxy, alkylaminocarbonyloxy, dialkylaminocarbonyloxy, alkylarylaminocarbonyloxy, diarylaminocarbonyloxy, guanidino, isothioureido, ureido, N-alkylureido, N-arylureido, N′-alkylureido, N′,N′-dialkylureido, N′-alkyl-N′-arylureido, N′,N′-diarylureido, N′-arylureido, N,N′-dialkylureido, N-alkyl-N′-arylureido, N-aryl-N′-alkylureido, N,N′-diarylureido, N,N′,N′-trialkylureido, N,N′-dialkyl-N′-arylureido, N-alkyl-N′,N′-diarylureido, N-aryl-N′,N′-dialkylureido, N,N′-diaryl-N′-alkylureido, N,N′,N′-triarylureido, amidino, alkylamidino, arylamidino, aminothiocarbonyl, alkylaminothiocarbonyl, arylaminothiocarbonyl, amino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, arylaminoalkyl, diarylaminoalkyl, alkylarylaminoalkyl, alkylamino, dialkylamino, haloalkylamino, arylamino, diarylamino, alkylarylamino, alkylcarbonylamino, alkoxycarbonylamino, aralkoxycarbonylamino, arylcarbonylamino, arylcarbonylaminoalkyl, aryloxycarbonylaminoalkyl, aryloxyarylcarbonylamino, aryloxycarbonylamino, alkylsulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, heterocyclylsulfonylamino, heteroarylthio, azido, —N+R51R52R53, —P(R50)2, —P(═O)(R50)2, OP(═O)(R50)2, —NR60C(═O)R63, dialkylphosphonyl, alkylarylphosphonyl, diarylphosphonyl, hydroxyphosphonyl, alkylthio, arylthio, perfluoroalkylthio, hydroxycarbonylalkylthio, thiocyano, isothiocyano, alkylsulfinyloxy, alkylsulfonyloxy, arylsulfinyloxy, arylsulfonyloxy, hydroxysulfonyloxy, alkoxysulfonyloxy, aminosulfonyloxy, alkylaminosulfonyloxy, dialkylaminosulfonyloxy, arylaminosulfonyloxy, diarylaminosulfonyloxy, alkylarylaminosulfonyloxy, alkylsulfinyl, alkylsulfonyl, arylsulfinyl, arylsulfonyl, hydroxysulfonyl, alkoxysulfonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, diarylaminosulfonyl or alkylarylaminosulfonyl; or two Q2 groups, which substitute atoms in a 1, 2 or 1,3 arrangement, together form alkylene, alkyleneoxy (i.e., —O—(CH2)y—), alkylenethioxy (i.e., —S—(CH2)y—), alkylenedioxy (i.e., —O—(CH2)y—O—), thioalkylenoxy (i.e., —S—(CH2)y—O—) or alkylenedithioxy (i.e., —S—(CH2)y—S—) where y is 1 or 2; or two Q2 groups, which substitute the same atom, together form an alkylene;
R50 is hydroxy, alkoxy, aralkoxy, alkyl, heteroaryl, heterocyclyl, aryl or —NR70R71, where R70 and R71 are each independently hydrogen, alkyl, aralkyl, aryl, heteroaryl, heteroaralkyl or heterocyclyl, or R70 and R71 together form alkylene, azaalkylene, oxaalkylene or thiaalkylene;
R51, R52 and R53 are each independently hydrogen, alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heterocyclyl or heterocyclylalkyl;
R60 is hydrogen, alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heterocyclyl or heterocyclylalkyl; and
R63 is alkoxy, aralkoxy, alkyl, heteroaryl, heterocyclyl, aryl or —NR70R71.

### Claim 2 (depends on 1)

The compound of claim 1, wherein the compound has formula II:
or a pharmaceutically acceptable derivative thereof.

### Claim 3 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein A1 is arylele or heterocyclylene.

### Claim 4 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein A1 is 1,2-dihydropyridine, optionally substituted with an oxo group.

### Claim 5 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein A1 is phenyl or 2-oxo-1,2-dihydropyridinyl.

### Claim 6 (depends on 1)

The compound of claim 1, wherein the compound has formula III:
or a pharmaceutically acceptable derivative thereof, wherein
R5c is hydrogen or lower alkyl; and n, is 0 to 3.

### Claim 7 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R1 is aryl, aralkyl, alkylaryl, cycloalkyl, cycloalkylalkyl, heterocyclylalkyl or heteroarylalkyl.

### Claim 8 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R1 is benzyl, phenyl, 2,2-diphenylethyl, 3,3-diphenylpropyl, naphthylmethyl, diphenylmethyl, naphthyl or dithiophen-2-ylmethyl.

### Claim 9 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R1 is optionally substituted with one, two, three or four groups, selected from alkyl, halo, haloalkyl, aryl, aralkyl, alkylaryl, haloaryl, alkoxy, haloaryl and haloalkylaryl.

### Claim 10 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R1 has formula:
where n3 is 0 to 3;
n4 is 0 to 5;
R11 is hydrogen, alkyl, aryl, alkylaryl, haloaryl or haloalkylaryl; and
R10 is hydrogen, alkyl, halo, haloalkyl, aryl, aralkyl, alkylaryl, haloaryl, alkoxy, haloaryl or haloalkylaryl.

### Claim 11 (depends on 10)

The compound of claim 10, or a pharmaceutically acceptable derivative thereof, wherein R11 is hydrogen, methyl, phenyl, o-tolyl, m-tolyl, p-tolyl, 4-fluorophenyl, 3-fluorophenyl, 2-fluorophenyl, 3,5-dimethylphenyl, 3-trifluoromethylphenyl or 4-trifluoromethylphenyl.

### Claim 12 (depends on 10)

The compound of claim 10, or a pharmaceutically acceptable derivative thereof, wherein R10 is hydrogen, methyl, fluoro, bromo, isopropyl, phenyl, benzyl, naphthyl, isopropylphenyl, fluorophenyl or methoxy.

### Claim 13 (depends on 10)

The compound of claim 10, or a pharmaceutically acceptable derivative thereof, wherein n3 is 0, 1, 2 or 3.

### Claim 14 (depends on 10)

The compound of claim 10, or a pharmaceutically acceptable derivative thereof, wherein n3 is 1 or 2.

### Claim 15 (depends on 10)

The compound of claim 10, wherein R1 has formula:
or a pharmaceutically acceptable derivative thereof, wherein R10 is hydrogen, methyl, fluoro, chloro, bromo, iodo, isopropyl, trifluoromethyl, phenyl, benzyl, naphthyl, isopropylphenyl, fluorophenyl or methoxy; R11a is hydrogen, methyl, fluoro or trifluoromethyl and n5 is 1, 2 or 3.

### Claim 16 (depends on 10)

The compound of claim 10, or a pharmaceutically acceptable derivative thereof, wherein R1 has formula:

### Claim 17 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R2 is hydrogen or lower alkyl.

### Claim 18 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R2 is hydrogen.

### Claim 19 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R3 is hydrogen, lower alkyl or aryl.

### Claim 20 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R3 is hydrogen, methyl, ethyl, or phenyl.

### Claim 21 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R3 is hydrogen.

### Claim 22 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R5 is hydroxy or alkoxy.

### Claim 23 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R5 is hydroxy or methoxy.

### Claim 24 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R4 is alkyl, —C(═NR)R, C(═R6)NR7R8, C(O)R9 or S(O)nR9.

### Claim 25 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R4 is aryloxycarbonyl, alkylarylsulfonyl, heterocyclylsulfonyl, alkylsulfonyl, haloalkylsulfonyl, heterocyclyl, heteroaryl or C(═R6)NR7R8.

### Claim 26 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R4 is hydrogen, ethyl, benzyloxycarbonyl, p-tolylsulfonyl, methylsulfonyl, trifluoromethylsulfonyl, 4,5-dihydro-1H-imidazol-2-yl, pyrimidin-2-yl or C(═R6)NR7R8.

### Claim 27 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R4 is —C(═R6)NR7R8 or —C(═R6)NR7R8, wherein
R6 is NR6x or O;
R6x is hydrogen, hydroxy, alkyl, —C(O)R9 or —S(O)nR9;
R7 is hydrogen or alkyl; and
R8 is hydrogen, alkyl, nitro, C(O)R9 or S(O)nR9; and
each R is independently selected from hydrogen, hydroxy, alkyl, carboxyalkyl, cycloalkyl, alkoxycarbonyl, aryl and heteroaryl.

### Claim 28 (depends on 24)

The compound of claim 24, or a pharmaceutically acceptable derivative thereof, wherein R6 is NR6x or O;
R6x is hydrogen, methyl or ethoxycarbonyl;
R7 is hydrogen; and
R8 is hydrogen, nitro, ethoxycarbonyl or p-tolylsulfonyl.

### Claim 29 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R4 has formula:
where R6x is hydrogen, hydroxy, methyl or ethoxycarbonyl; R8 is hydrogen, nitro, ethoxycarbonyl or p-tolylsulfonyl; Rm is hydrogen, hydroxy or alkyl; and Rn is hydrogen, alkyl, cycloalkyl, aryl, alkoxycarbonylalyl or carboxyalkyl.

### Claim 30 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein R4 has formula:

### Claim 31 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein A4 is alkylene or arylene.

### Claim 32 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein A4 is —(CH2)n2— or phenylene and n2 is 1-5.

### Claim 33 (depends on 10)

The compound of claim 10, or a pharmaceutically acceptable derivative thereof, wherein the compound has formula:
where R4 is —C(═NH)NH2; n2 is 3; R2R3 and R5 are each hydrogen and R1 is selected from

### Claim 34 (depends on 1)

The compound of claim 1, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 35 (depends on 10)

The compound of claim 10, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 36 (depends on 10)

The compound of claim 10, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 37 (depends on 10)

The compound of claim 10, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof, where A5 is
and where A5 is optionally substituted with one, two or three groups selected from halo, alkyl, and alkoxy.

### Claim 38 (depends on 1)

The compound of claim 1, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 39 (depends on 1)

The compound of claim 1, wherein
or a pharmaceutically acceptable derivative thereof.

### Claim 40 (depends on 1)

The compound of claim 1, wherein
or a pharmaceutically acceptable derivative thereof.

### Claim 41 (depends on 40)

The compound of claim 40, wherein
or a pharmaceutically acceptable derivative thereof.

### Claim 42 (depends on 41)

The compound of claim 41, wherein
or a pharmaceutically acceptable derivative thereof.

### Claim 43 (depends on 1)

The compound of claim 1, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 44 (depends on 43)

The compound of claim 43, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 45 (depends on 1)

The compound of claim 1, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof, wherein
W is O or S;
R is aralkyl;
A4 is alkylene;
R1 is alkyl, aralkyl or heteroaralkyl, optionally substituted with one or two alkyl or halo;
R2 is hydrogen or alkyl
R5c is hydrogen or alkyl;
R5a and R5b are selected as follows:
R3 is hydrogen or alkyl;
R4 is alkyl, —C(═R6)NR7R8 or —C(═NRm)Rn;
Rm is hydrogen or hydroxy;
Rn is hydrogen, alkyl, aryl, heteroaryl, cycloalkyl, alkoxycarbonylalkyl or hydroxy;
R6 is NR6x;
R6x is hydrogen, OH or alkyl;
R7 is hydrogen or alkyl; and
R8 is hydrogen or alkyl.

### Claim 46 (depends on 45)

The compound of claim 45 having formula:
or a pharmaceutically acceptable derivative thereof, where each Rp is independently hydrogen, halo or alkyl; and p1 is 1 or 2.

### Claim 47

A compound of formula:
or a pharmaceutically acceptable derivative thereof, wherein
R1a is aryl, aralkyl, alkylaryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heteroarylalkyl;
R2a and R3a are each independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl;
R5d is ORa or NR5eR5f;
Ra is hydrogen, alkyl, alkenyl, alkynyl, aryl, alkylaryl, heteroaryl, heterocyclyl, cycloalkyl or aralkyl;
R5e and R5f are selected as follows:
i) R5e and R5f are each independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl; or
ii) R5e and R5f together with the nitrogen atom on which they are substituted form a 3-7 membered heterocyclic or heteroaryl ring;
A4 is alkylene, alkenylene, alkynylene, alk(en)(yn)ylene, cycloalkylene, arylene, aralkylene, alkylarylene, heteroarylene or heterocyclylene;
R4a is
R6a is hydrogen, alkyl, alkenyl, alkynyl, aryl, C(O)R9a or S(O)pR9a;
R7a and R8a are selected as follows:
i) R7a is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl; and R8a is selected from R7a, nitro, C(O)R9a and S(O)pR9a; or
ii) R7a and R8a together with the nitrogen atom on which they are substituted form a 3-7 membered heterocyclic or heteroaryl ring;
R9a is hydrogen, hydroxy, alkyl, haloalkyl, alkenyl, alkynyl, aryl, alkylaryl, heterocyclyl, cycloalkyl, aralkyl, alkoxy, alkenyloxy, alkynyloxy, aryloxy, alkylaryloxy, heterocyclyloxy, cycloalkyloxy or aralkoxy;
Rx and Ry are selected as follows:
i) Rx and Ry are each independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl; or
ii) Rx and Ry together with the carbon on which they are substituted form a 3-7 membered ring;
r2 is 0-3 and p is 0-2,
where R1a, R2a, R3a, R6a, R7a, R8a, R5d, Rx, Ry, A4a, R5e and R5f are optionally substituted with 1, 2, 3 or 4 substituents, each independently selected from Q1, where Q1 is halo, pseudohalo, hydroxy, oxo, thioxo, nitrile, nitro, formyl, mercapto, hydroxycarbonyl, hydroxycarbonylalkyl, alkyl, haloalkyl, polyhaloalkyl, aminoalkyl, diaminoalkyl, alkenyl containing 1 to 2 double bonds, alkynyl containing 1 to 2 triple bonds, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, aryl, heteroaryl, aralkyl, aralkenyl, aralkynyl, heteroarylalkyl, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl, triarylsilyl, alkylidene, arylalkylidene, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, alkoxycarbonylalkyl, aryloxycarbonyl, aryloxycarbonylalkyl, aralkoxycarbonyl, aralkoxycarbonylalkyl, arylcarbonylalkyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, arylaminocarbonyl, diarylaminocarbonyl, arylalkylaminocarbonyl, alkoxy, aryloxy, heteroaryloxy, heteroaralkoxy, heterocyclyloxy, cycloalkoxy, perfluoroalkoxy, alkenyloxy, alkynyloxy, aralkoxy, alkylcarbonyloxy, arylcarbonyloxy, aralkylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, aralkoxycarbonyloxy, aminocarbonyloxy, alkylaminocarbonyloxy, dialkylaminocarbonyloxy, alkylarylaminocarbonyloxy, diarylaminocarbonyloxy, guanidino, isothioureido, ureido, N-alkylureido, N-arylureido, N′-alkylureido, N′,N′-dialkylureido, N′-alkyl-N′-arylureido, N′,N′-diarylureido, N′-arylureido, N,N′-dialkylureido N-alkyl-N′-arylureido, N-aryl-N′-alkylureido, N,N′-diarylureido, N,N′,N′-trialkylureido, N,N′-dialkyl-N′-arylureido, N-alkyl-N′,N′-diarylureido, N-aryl-N′,N′-dialkylureido, N,N′-diaryl-N′-alkylureido, N,N′,N′-triarylureido, amidino, alkylamidino, arylamidino, aminothiocarbonyl, alkylaminothiocarbonyl, arylaminothiocarbonyl, amino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, arylaminoalkyl, diarylaminoalkyl, alkylarylaminoalkyl, alkylamino, dialkylamino, haloalkylamino, arylamino, diarylamino, alkylarylamino, alkylcarbonylamino, alkoxycarbonylamino, aralkoxycarbonylamino, arylcarbonylamino, arylcarbonylaminoalkyl, aryloxycarbonylaminoalkyl, aryloxyarylcarbonylamino, aryloxycarbonylamino, alkylsulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, heterocyclylsulfonylamino, heteroarylthio, azido, —NR51R52R53P(R50)2, P(═O)(R50)2, OP(═O)(R50)2, —NR60C(═O)R63, dialkylphosphonyl, alkylarylphosphonyl, diarylphosphonyl, hydroxyphosphonyl, alkylthio, arylthio, perfluoroalkylthio, hydroxycarbonylalkylthio, thiocyano, isothiocyano, alkylsulfinyloxy, alkylsulfonyloxy, arylsulfinyloxy, arylsulfonyloxy, hydroxysulfonyloxy, alkoxysulfonyloxy, aminosulfonyloxy, alkylaminosulfonyloxy, dialkylaminosulfonyloxy, arylaminosulfonyloxy, diarylaminosulfonyloxy, alkylarylaminosulfonyloxy, alkylsulfinyl, alkylsulfonyl, arylsulfinyl, arylsulfonyl, hydroxysulfonyl, alkoxysulfonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, diarylaminosulfonyl or alkylarylaminosulfonyl; or two Q1 groups, which substitute atoms in a 1, 2 or 1,3 arrangement, together form alkylene, alkyleneoxy (i.e., —O—(CH2)y—), alkylenethioxy (i.e., —S—(CH2)y—), alkylenedioxy (i.e., —O—(CH2)y—O—), thioalkylenoxy (i.e., —S—(CH2)y—O—) or alkylenedithioxy (i.e., —S—(CH2)y—S—) where y is 1 or 2; or two Q1 groups, which substitute the same atom, together form an alkylene; and
each Q1 is independently unsubstituted or substituted with one, two or three substituents, each independently selected from Q2;
each Q2 is independently halo, pseudohalo, hydroxy, oxo, thioxo, nitrile, nitro, formyl, mercapto, hydroxycarbonyl, hydroxycarbonylalkyl, alkyl, haloalkyl, polyhaloalkyl, aminoalkyl, diaminoalkyl, alkenyl containing 1 to 2 double bonds, alkynyl containing 1 to 2 triple bonds, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, aryl, heteroaryl, aralkyl, aralkenyl, aralkynyl, heteroarylalkyl, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl, triarylsilyl, alkylidene, arylalkylidene, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, alkoxycarbonylalkyl, aryloxycarbonyl, aryloxycarbonylalkyl, aralkoxycarbonyl, aralkoxycarbonylalkyl, arylcarbonylalkyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, arylaminocarbonyl, diarylaminocarbonyl, arylalkylaminocarbonyl, alkoxy, aryloxy, heteroaryloxy, heteroaralkoxy, heterocyclyloxy, cycloalkoxy, perfluoroalkoxy, alkenyloxy, alkynyloxy, aralkoxy, alkylcarbonyloxy, arylcarbonyloxy, aralkylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, aralkoxycarbonyloxy, aminocarbonyloxy, alkylaminocarbonyloxy, dialkylaminocarbonyloxy, alkylarylaminocarbonyloxy, diarylaminocarbonyloxy, guanidino, isothioureido, ureido, N-alkylureido, N-arylureido, N′-alkylureido, N′,N′-dialkylureido, N′-alkyl-N′-arylureido, N′,N′-diarylureido, N′-arylureido, N,N′-dialkylureido, N-alkyl-N′-arylureido, N-aryl-N′-alkylureido, N,N′-diarylureido, N,N′,N′-trialkylureido, N,N′-dialkyl-N′-arylureido, N-alkyl-N′,N′-diarylureido, N-aryl-N′,N′-dialkylureido, N,N′-diaryl-N′-alkylureido, N,N′,N′-triarylureido, amidino, alkylamidino, arylamidino, aminothiocarbonyl, alkylaminothiocarbonyl, arylaminothiocarbonyl, amino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, arylaminoalkyl, diarylaminoalkyl, alkylarylaminoalkyl, alkylamino, dialkylamino, haloalkylamino, arylamino, diarylamino, alkylarylamino, alkylcarbonylamino, alkoxycarbonylamino, aralkoxycarbonylamino, arylcarbonylamino, arylcarbonylaminoalkyl, aryloxycarbonylaminoalkyl, aryloxyarylcarbonylamino, aryloxycarbonylamino, alkylsulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, heterocyclylsulfonylamino, heteroarylthio, azido, —N+R51R52R53, P(R50)2, P(═O)(R50)2, OP(═O)(R50)2, —NR60C(═O)R63, dialkylphosphonyl, alkylarylphosphonyl, diarylphosphonyl, hydroxyphosphonyl, alkylthio, arylthio, perfluoroalkylthio, hydroxycarbonylalkylthio, thiocyano, isothiocyano, alkylsulfinyloxy, alkylsulfonyloxy, arylsulfinyloxy, arylsulfonyloxy, hydroxysulfonyloxy, alkoxysulfonyloxy, aminosulfonyloxy, alkylaminosulfonyloxy, dialkylaminosulfonyloxy, arylaminosulfonyloxy, diarylaminosulfonyloxy, alkylarylaminosulfonyloxy, alkylsulfinyl, alkylsulfonyl, arylsulfinyl, arylsulfonyl, hydroxysulfonyl, alkoxysulfonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, diarylaminosulfonyl or alkylarylaminosulfonyl; or two Q2 groups, which substitute atoms in a 1, 2 or 1,3 arrangement, together form alkylene, alkyleneoxy (i.e., —O—(CH2)y—), alkylenethioxy (i.e., —S—(CH2)y—), alkylenedioxy (i.e., —O—(CH2)y—O—), thioalkylenoxy (i.e. —S—(CH2)y—O—) or alkylenedithioxy (i.e., —S—(CH2)y—S—) where y is 1 or 2; or two Q2 groups, which substitute the same atom, together form an alkylene;
R50 is hydroxy, alkoxy, aralkoxy, alkyl, heteroaryl, heterocyclyl, aryl or —NR70R71, where R70 and R71 are each independently hydrogen, alkyl, aralkyl, aryl, heteroaryl, heteroaralkyl or heterocyclyl, or R70 and R71 together form alkylene, azaalkylene, oxaalkylene or thiaalkylene;
R51, R52 and R53 are each independently hydrogen, alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heterocyclyl or heterocyclylalkyl;
R60 is hydrogen, alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heterocyclyl or heterocyclylalkyl; and
R63 is alkoxy, aralkoxy, alkyl, heteroaryl, heterocyclyl, aryl or —NR70R71.

### Claim 48 (depends on 47)

The compound of claim 47, wherein Rx and Ry are selected as follows:
i) Rx and Ry are each independently alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl; or
ii) Rx and Ry together with the carbon on which they are substituted form a 3-7 membered ring.

### Claim 49 (depends on 47)

The compound of claim 47, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 50 (depends on 49)

The compound of claim 49, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 51 (depends on 50)

The compound of claim 50, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof, where Rx and Ry are both methyl.

### Claim 52

A compound of formula:
or a pharmaceutically acceptable derivative thereof, wherein
R1c is aralkyl;
R2c is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl;
R5h is ORc or NR5iR5j;
Rc is hydrogen, alkyl, alkenyl, alkynyl, aryl, alkylaryl, heteroaryl, heterocyclyl, cycloalkyl or aralkyl;
R5i and R5j are selected as follows:
i) R5i and R5j are each independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl; or
ii) R5i and R5j together with the nitrogen atom on which they are substituted form a 3-7 membered heterocyclic or heteroaryl ring;
A4c is alkylene, alkenylene, alkynylene, alk(en)(yn)ylene, cycloalkylene, arylene, aralkelene, alkylarylene, heteroarylene or heterocyclylene;
R4c is R5h
R6c is NR6y or O;
R6y is hydrogen, alkyl, alkenyl, alkynyl, aryl, C(O)R9c or S(O)pR9c;
R7c and R8c are selected as follows:
i) R7c is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl or heterocyclyl; and R8c is selected from R7c, nitro, C(O)R9c and S(O)pR9c; or
ii) R7c and R8c together with the nitrogen atom on which they are substituted form a 3-7 membered heterocyclic or heteroaryl ring;
R9c is hydrogen, hydroxy, alkyl, haloalkyl, alkenyl, alkynyl, aryl, alkylaryl, heterocyclyl, cycloalkyl, aralkyl, alkoxy, alkenyloxy, alkynyloxy, aryloxy, alkylaryloxy, heterocyclyloxy, cycloalkyloxy or aralkoxy;
r3 is 0-3; p is 0-2 and n6 is 0-3, and
where R1c, R2c, R4c, R5h, Rc, R5i, R5j and A4c are optionally substituted with 1, 2, 3 or 4 substituents, each independently selected from Q1, where Q1 is halo, pseudohalo, hydroxy, oxo, thioxo, nitrile, nitro, formyl, mercapto, hydroxycarbonyl, hydroxycarbonylalkyl, alkyl, haloalkyl, polyhaloalkyl, aminoalkyl, diaminoalkyl, alkenyl containing 1 to 2 double bonds, alkynyl containing 1 to 2 triple bonds, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, aryl, heteroaryl, aralkyl, aralkenyl, aralkynyl, heteroarylalkyl, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl, triarylsilyl, alkylidene, arylalkylidene, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, alkoxycarbonylalkyl, aryloxycarbonyl, aryloxycarbonylalkyl, aralkoxycarbonyl, aralkoxycarbonylalkyl, arylcarbonylalkyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, arylaminocarbonyl, diarylaminocarbonyl, arylalkylaminocarbonyl, alkoxy, aryloxy, heteroaryloxy, heteroaralkoxy, heterocyclyloxy, cycloalkoxy, perfluoroalkoxy, alkenyloxy, alkynyloxy, aralkoxy, alkylcarbonyloxy, arylcarbonyloxy, aralkylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, aralkoxycarbonyloxy, aminocarbonyloxy, alkylaminocarbonyloxy, dialkylaminocarbonyloxy, alkylarylaminocarbonyloxy, diarylaminocarbonyloxy, guanidino, isothioureido, ureido, N-alkylureido, N-arylureido, N′-alkylureido, N′,N′-dialkylureido, N′-alkyl-N′-arylureido, N′,N′-diarylureido, N′-arylureido, N,N′-dialkylureido, N-alkyl-N′-arylureido, N-aryl-N′-alkylureido, N,N′-diarylureido, N,N′,N′-trialkylureido, N,N′-dialkyl-N′-arylureido, N-alkyl-N′,N′-diarylureido, N-aryl-N′,N′-dialkylureido, N,N′-diaryl-N′-alkylureido, N,N′,N′-triarylureido, amidino, alkylamidino, arylamidino, aminothiocarbonyl, alkylaminothiocarbonyl, arylaminothiocarbonyl, amino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, arylaminoalkyl, diarylaminoalkyl, alkylarylaminoalkyl, alkylamino, dialkylamino, haloalkylamino, arylamino, diarylamino, alkylarylamino, alkylcarbonylamino, alkoxycarbonylamino, aralkoxycarbonylamino, arylcarbonylamino, arylcarbonylaminoalkyl, aryloxycarbonylaminoalkyl, aryloxyarylcarbonylamino, aryloxycarbonylamino, alkylsulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, heterocyclylsulfonylamino, heteroarylthio, azido, —N+R51R52R53, P(R50)2, P(═O)(R50)2, OP(═O)(R50)2, —NR60C(═O)R63, dialkylphosphonyl, alkylarylphosphonyl, diarylphosphonyl, hydroxyphosphonyl, alkylthio, arylthio, perfluoroalkylthio, hydroxycarbonylalkylthio, thiocyano, isothiocyano, alkylsulfinyloxy, alkylsulfonyloxy, arylsulfinyloxy, arylsulfonyloxy, hydroxysulfonyloxy, alkoxysulfonyloxy, aminosulfonyloxy, alkylaminosulfonyloxy, dialkylaminosulfonyloxy, arylaminosulfonyloxy, diarylaminosulfonyloxy, alkylarylaminosulfonyloxy, alkylsulfinyl, alkylsulfonyl, arylsulfinyl, arylsulfonyl, hydroxysulfonyl, alkoxysulfonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, diarylaminosulfonyl or alkylarylaminosulfonyl; or two Q1 groups, which substitute atoms in a 1, 2 or 1,3 arrangement, together form alkylene, alkyleneoxy (i.e., —O—(CH2)y—), alkylenethioxy (i.e., —S—(CH2)y—), alkylenedioxy (i.e., —O—(CH2)y—O—), thioalkylenoxy (i.e., —S—(CH2)y—O—) or alkylenedithioxy (i.e., —S—(CH2)y—S—) where y is 1 or 2; or two Q1 groups, which substitute the same atom, together form an alkylene; and
each Q1 is independently unsubstituted or substituted with one, two or three substituents, each independently selected from Q2;
each Q2 is independently halo, pseudohalo, hydroxy, oxo, thioxo, nitrile, nitro, formyl, mercapto, hydroxycarbonyl, hydroxycarbonylalkyl, alkyl, haloalkyl, polyhaloalkyl, aminoalkyl, diaminoalkyl, alkenyl containing 1 to 2 double bonds, alkynyl containing 1 to 2 triple bonds, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, aryl, heteroaryl, aralkyl, aralkenyl, aralkynyl, heteroarylalkyl, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl, triarylsilyl, alkylidene, arylalkylidene, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, alkoxycarbonylalkyl, aryloxycarbonyl, aryloxycarbonylalkyl, aralkoxycarbonyl, aralkoxycarbonylalkyl, arylcarbonylalkyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, arylaminocarbonyl, diarylaminocarbonyl, arylalkylaminocarbonyl, alkoxy, aryloxy, heteroaryloxy, heteroaralkoxy, heterocyclyloxy, cycloalkoxy, perfluoroalkoxy, alkenyloxy, alkynyloxy, aralkoxy, alkylcarbonyloxy, arylcarbonyloxy, aralkylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, aralkoxycarbonyloxy, aminocarbonyloxy, alkylaminocarbonyloxy, dialkylaminocarbonyloxy, alkylarylaminocarbonyloxy, diarylaminocarbonyloxy, guanidino, isothioureido, ureido, N-alkylureido, N-arylureido, N′-alkylureido, N′,N′-dialkylureido, N′-alkyl-N′-arylureido, N′,N′-diarylureido, N′-arylureido, N,N′-dialkylureido, N-alkyl-N′-arylureido, N-aryl-N′-alkylureido, N,N′-diarylureido, N,N′,N′-trialkylureido, N,N′-dialkyl-N′-arylureido, N-alkyl-N′,N′-diarylureido, N-aryl-N′,N′-dialkylureido, N,N′-diaryl-N′-alkylureido, N,N′,N′-triarylureido, amidino, alkylamidino, arylamidino, aminothiocarbonyl, alkylaminothiocarbonyl, arylaminothiocarbonyl, amino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, arylaminoalkyl, diarylaminoalkyl, alkylarylaminoalkyl, alkylamino, dialkylamino, haloalkylamino, arylamino, diarylamino, alkylarylamino, alkylcarbonylamino, alkoxycarbonylamino, aralkoxycarbonylamino, arylcarbonylamino, arylcarbonylaminoalkyl, aryloxycarbonylaminoalkyl, aryloxyarylcarbonylamino, aryloxycarbonylamino, alkylsulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, heterocyclylsulfonylamino, heteroarylthio, azido, —N+R51R52R53, P(R50)2, P(═O)(R50)2, OP(═O)(R50)2, —NR60C(═O)R63, dialkylphosphonyl, alkylarylphosphonyl, diarylphosphonyl, hydroxyphosphonyl, alkylthio, arylthio, perfluoroalkylthio, hydroxycarbonylalkylthio, thiocyano, isothiocyano, alkylsulfinyloxy, alkylsulfonyloxy, arylsulfinyloxy, arylsulfonyloxy, hydroxysulfonyloxy, alkoxysulfonyloxy, aminosulfonyloxy, alkylaminosulfonyloxy, dialkylaminosulfonyloxy, arylaminosulfonyloxy, diarylaminosulfonyloxy, alkylarylaminosulfonyloxy, alkylsulfinyl, alkylsulfonyl, arylsulfinyl, arylsulfonyl, hydroxysulfonyl, alkoxysulfonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, diarylaminosulfonyl or alkylarylaminosulfonyl; or two Q2 groups, which substitute atoms in a 1, 2 or 1,3 arrangement, together form alkylene, alkyleneoxy (i.e., —O—(CH2)y—), alkylenethioxy (i.e., —S—(CH2)y—), alkylenedioxy (i.e., —O—(CH2)y—O—), thioalkylenoxy (i.e., —S—(CH2)y—O—) or alkylenedithioxy (i.e., —S—(CH2)y—S—) where y is 1 or 2; or two Q2 groups, which substitute the same atom, together form an alkylene;
R50 is hydroxy, alkoxy, aralkoxy, alkyl, heteroaryl, heterocyclyl, aryl or —NR70R71,
where R70 and R71 are each independently hydrogen, alkyl, aralkyl, aryl, heteroaryl, heteroaralkyl or heterocyclyl, or R70 and R71 together form alkylene, azaalkylene, oxaalkylene or thiaalkylene;
R51, R52 and R53 are each independently hydrogen, alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heterocyclyl or heterocyclylalkyl;
R60 is hydrogen, alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heterocyclyl or heterocyclylalkyl; and
R63 is alkoxy, aralkoxy, alkyl, heteroaryl, heterocyclyl, aryl or —NR70R71.

### Claim 53 (depends on 52)

The compound of claim 52, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 54 (depends on 52)

The compound of claim 52, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 55 (depends on 52)

The compound of claim 52, wherein the compound has formula:
where n6 is 1-5, or a pharmaceutically acceptable derivative thereof.

### Claim 56 (depends on 52)

The compound of claim 52, wherein the compound has formula:
or a pharmaceutically acceptable derivative thereof.

### Claim 57 (depends on 1)

The compound of claim 1, selected from:
and pharmaceutically acceptable derivatives thereof.

### Claim 58 (depends on 1)

The compound of claim 1, selected from:
and pharmaceutically acceptable derivatives thereof.

### Claim 59 (depends on 1)

The compound of claim 1, selected from:
and pharmaceutically acceptable derivatives thereof.

### Claim 60 (depends on 1)

The compound of claim 1, selected from:
and pharmaceutically acceptable derivatives thereof.

### Claim 61 (depends on 1)

The compound of claim 1, selected from:
and pharmaceutically acceptable derivatives thereof.

### Claim 62 (depends on 47)

The compound of claim 47, wherein the compound is:
or a pharmaceutically acceptable derivative thereof.

### Claim 63 (depends on 52)

The compound of claim 52, selected from:
or a pharmaceutically acceptable derivative thereof.

### Claim 64 (depends on 1)

The compound of claim 1, selected from
or a pharmaceutically acceptable derivative thereof.

### Claim 65 (depends on 1)

A pharmaceutical composition comprising a compound of claim 1 or a pharmaceutically acceptable derivative thereof, and a pharmaceutically acceptable carrier.

### Claim 66 (depends on 1)

A method for modulating C3a receptor activity comprising contacting the C3a receptor with the compound of claim 1 or a pharmaceutically acceptable derivative thereof.

### Claim 67 (depends on 1)

A method for treating, preventing or ameliorating a disease associated with C3a receptor modulation comprising administering the compound of claim 1 or a pharmaceutically acceptable derivative thereof.

### Claim 68 (depends on 67)

The method of claim 67, wherein the disease is acute and chronic inflammatory disease, atherosclerosis, chronic polyarthritis, systemic vasculitis, multiple sclerosis, Alzheimer's Disease, CNS inflammatory disease, Crohn's Disease, food allergy, non-bronchial allergy, osteoarthritis, osteoporosis, thyroid disease, coronary heart disease, renal disease, rheumatological disease, neurological diseases, dermatological disease, biocompatibility/shock disease, atheroma, bowel inflammation, thyroiditis, infertility, suseptibility to pyogenic infections, glomerulonephritis, suseptibility to neisserial infections, recurrent subcutaneous swelling, mucosal oedema, and recurrent episodes of thrombosis/haemolysis.

### Claim 69 (depends on 47)

A pharmaceutical composition comprising a compound of claim 47 or a pharmaceutically acceptable derivative thereof, and a pharmaceutically acceptable carrier.

### Claim 70 (depends on 47)

A method for treating, preventing or ameliorating a disease associated with C3a receptor modulation comprising administering the compound of claim 47 or a pharmaceutically acceptable derivative thereof.

### Claim 71 (depends on 52)

A pharmaceutical composition comprising a compound of claim 52 or a pharmaceutically acceptable derivative thereof, and a pharmaceutically acceptable carrier.

### Claim 72 (depends on 52)

A method for treating, preventing or ameliorating a disease associated with C3a receptor modulation comprising administering the compound of claim 52 or a pharmaceutically acceptable derivative thereof.
